Our purpose is to provide life-transforming medicines for the treatment of moderate to severe opioid use disorder and serious mental illness with a global portfolio in 37 countries.
We understand that access to evidence-based treatment, including counseling, are critical to ensuring that patients struggling with opioid use disorder and serious mental illnesses, like schizophrenia, get the medical care they deserve and need, just as patients with other chronic diseases receive the care they require.
Indivior is pioneering the development and discovery of new therapies to potentially address the needs of people suffering from substance use disorders.
We are constantly investigating new areas of understanding, new approaches to treatment and new methodologies to support measurement of clinical response.
Externally Sponsored Studies and Independent Medical Education Grants
We support externally-sponsored studies and independent medical education grants that are consistent with Indivior areas of research interest and education areas of interest, respectively.
